* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Chapter_008
Survey
Document related concepts
Transcript
Chapter 8 Alterations in Immunity and Inflammation Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. Hypersensitivity Altered immunologic response to an antigen; results in disease/damage to host Allergy • Deleterious effects of hypersensitivity to environmental (exogenous) antigens Autoimmunity • Disturbance in immunologic tolerance of self-antigens Alloimmunity • Immune reaction to tissues of another individual Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Hypersensitivity Characterized by the immune mechanism Type I • IgE mediated Type II • Tissue-specific reactions Type III • Immune complex mediated Type IV • Cell mediated Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 3 Hypersensitivity Immediate hypersensitivity reactions Anaphylaxis Delayed hypersensitivity reactions Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 4 Type I Hypersensitivity IgE mediated Against environmental antigens (allergens) IgE binds to Fc receptors on surface of mast cells (cytotropic antibody) Histamine release H1 and H2 receptors Antihistamines Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 5 Type I Mast Cell Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 6 Type I Hypersensitivity Manifestations Itching Urticaria Conjunctivitis Rhinitis Hypotension Bronchospasm Dysrhythmias GI cramps and malabsorption Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 7 Clinical Symptoms of IgE Type I Reactions Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 8 Anaphylaxis Severity depends on level of sensitization Can be very small dose (ordinary skin testing) Within minutes after exposure: Itching Hives Skin erythema Contraction of respiratory bronchioles Laryngeal edema results in hoarseness Vomiting, abdominal cramps, diarrhea Laryngeal obstruction Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 9 Type I Hypersensitivity Genetic predisposition Tests Food challenges Skin tests Laboratory tests Desensitization IgG-blocking antibodies Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 10 Type II Hypersensitivity Tissue specific Specific cell or tissue (tissue-specific antigens) is the target of an immune response Five mechanisms Cell is destroyed by antibodies and complement Cell destruction through phagocytosis Soluble antigen may enter the circulation and deposit on tissues Antibody-dependent cell-mediated cytotoxicity Causes target cell malfunction Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 11 Phagocytosis Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 12 Neutrophil-Mediated Damage Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 13 Antibody-Dependent Cell-Mediated Cytotoxicity Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 14 Induced Cell Malfunction Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 15 Type III Hypersensitivity Immune complex mediated Antigen-antibody complexes formed in the circulation and later deposited in vessel walls or extravascular tissues Not organ specific Immune complex clearance Large—macrophages Small—renal clearance Intermediate—deposit in tissues Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 16 Type III Hypersensitivity Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 17 Examples of Immune Complex– Mediated Diseases: Type III Systemic lupus erythematosus Vasculitis Poststreptococcal glomerulonephritis Acute glomerulonephritis Reactive arthritis Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 18 Type IV Hypersensitivity Mediated by T lymphocytes Destruction of the tissue usually caused by direct killing by toxins from Tc cells Th1 cells produce cytokines that recruit phagocytes, especially macrophages Examples Acute graft rejection, skin test for TB, contact allergic reactions, and some autoimmune diseases Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 19 Type IV Hypersensitivity Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 20 Type IV Hypersensitivity Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 21 Antigenic Targets of Hypersensitivity Reactions Allergy Autoimmunity Environmental Ags Self Ags, with damage to host tissues Alloimmunity Against foreign tissue Ags Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 22 Allergy Environmental antigens that cause atypical immunologic responses in genetically predisposed individuals Pollens, molds, fungi, foods, animals, etc. Allergen contained within a particle too large to be phagocytosed or is protected by a nonallergenic coat Original insult is apparent Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 23 Autoimmunity Breakdown of tolerance Sequestered antigen Self-antigens not normally seen by the immune system Infectious disease Body recognizes self-antigens as foreign Molecular mimicry Neoantigen Haptens become immunogenic when they bind to host proteins Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 24 Autoimmunity Forbidden clone Ineffective peripheral tolerance During differentiation, lymphocytes produce receptors that react with self-antigens Defects in regulatory cells Original insult Genetic factors Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 25 Autoimmune Examples Systemic lupus erythematosus (SLE) Chronic multisystem inflammatory disease Autoantibodies against: • Nucleic acids, erythrocytes, coagulation proteins, phospholipids, lymphocytes, platelets, etc. Deposition of circulating immune complexes containing antibody against host DNA More common in females Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 26 Systemic Lupus Erythematosus Clinical manifestations Arthralgias or arthritis (90% of individuals) Vasculitis and rash (70%–80%) Renal disease (40%–50%) Hematologic changes (50%) Cardiovascular disease (30%–50%) Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 27 Systemic Lupus Erythematosus Eleven common findings Serial or simultaneous presence of at least four indicates SLE Facial (malar) rash, discoid rash, photosensitivity, oral or nasopharyngeal ulcers, nonerosive arthritis, serositis, renal disorders, neurologic disorders, hematologic disorders, immunologic disorders, and presence of antinuclear antibodies (ANAs) Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 28 Alloimmunity Immune system reacts with antigens on the tissue of other genetically dissimilar members of the same species Transient neonatal alloimmunity • Fetus expresses parental antigens not found in the mother Transplant rejection and transfusion reactions Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 29 Graft Rejection Transplant rejection classified according to time Hyperacute • Immediate and rare • Preexisting antibody to the antigens of the graft Acute • Cell-mediated response against unmatched HLA antigens Chronic • Months or years • Inflammatory damage to endothelial cells of vessels due to a weak cell-mediated reaction against minor HLA antigens Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 30 Transfusion Reactions Antibodies against blood group antigens ABO system Two major carbohydrate antigens • A and B (codominant) • Individuals have naturally occurring antibodies to the A • • • • and B antigens they lack Anti-A and anti-B antibody production is induced by similar antigens on naturally occurring bacteria in the intestinal tract Antibodies are usually of the IgM class O blood type (universal donor) AB blood type (universal recipient) Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 31 ABO Incompatibility: Alloimmune Reaction Blood type Ag Ab Incompatible with blood type A A Anti-B B, AB B B Anti-A A, AB AB Universal recipient A+B None None O Universal donor None Anti-A and Anti-B A, B, AB Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 32 Immunodeficiencies Result of impaired function of T cells, B cells, phagocytes and/or complement Primary (genetic) Secondary (acquired) Hallmark is recurrent infections often with opportunistic organisms Type of infection can lead to diagnosis of type of deficiency • Gonorrhea suggests complement deficiency • Viral infections suggest T cell deficiency Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 33 Immunodeficiencies Clinical presentation Development of unusual or recurrent, severe infections T cell deficiencies • Viral, fungal, yeast, and atypical microorganisms B cell and phagocyte deficiencies • Microorganisms requiring opsonization Complement deficiencies Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 34 Immunodeficiencies Primary (congenital) immunodeficiency Genetic anomaly Secondary (acquired) immunodeficiency Caused by another illness More common Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 35 Primary Immunodeficiencies Most are the result of a single gene defect Five groups B lymphocyte deficiencies T lymphocyte deficiencies Combined T and B cell deficiencies Complement defects Phagocyte defects Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 36 B Lymphocyte Deficiencies Hypogammaglobulinemia or agammaglobulinemia Bruton agammaglobulinemia Autosomal agammaglobulinemia X-linked hyper-IgM syndrome IgG subclass deficiency Selective IgA deficiency Common variable immunodeficiency Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 37 T Lymphocyte Deficiencies DiGeorge syndrome Partial or complete absence of T cell immunity Chronic mucocutaneous candidiasis Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 38 Combined T- and B-Cell Deficiencies Severe combined immunodeficiency (SCID) Reticular dysgenesis • Most severe form Adenosine deaminase (ADA) deficiency X-linked SCID JAK3 deficiency IL-7 receptor deficiency Purine nucleoside phosphorylase deficiency Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 39 Combined T and B Cell Deficiencies RAG-1 or RAG-2 deficiency Bare lymphocyte deficiency MHC class I and II deficiency Wiskott-Aldrich syndrome Ataxia-telangiectasia (AT) Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 40 Complement Deficiencies C3 deficiency Mannose-binding lectin (MBL) deficiency Properdin deficiency Factor I and factor H deficiency C9 deficiency Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 41 Complement Deficiencies Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 42 Phagocytic Deficiencies Severe congenital neutropenia Cyclic neutropenia Leukocyte adhesion deficiency (LAD) C3 receptor deficiency Chédiak-Higashi syndrome Myeloperoxidase deficiency Chronic granulomatous disease Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 43 Secondary Deficiencies Also referred to as acquired deficiencies Far more common than primary deficiencies Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 44 Secondary Deficiencies Causes Normal physiology conditions Psychologic stress Dietary insufficiencies Malignancies Physical trauma Medical treatments Infections AIDS Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 45 Graft-Versus-Host (GVH) Disease Immunocompromised individuals are at risk for GVH disease T cells in the graft are mature and capable of cellmediated destruction tissues within the recipient Not a problem if patient is immunocompetent Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 46 Evaluation of Immunity Complete blood count (CBC) with a differential Quantitative determination of immunoglobulins Subpopulations of lymphocytes Subpopulations of immunoglobulins Assay for total complement Skin tests Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 47 Treatment for Immunodeficiencies Gamma-globulin therapy Transplantation or transfusion Treatment with soluble immune mediators Gene therapy Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 48